PALMOPLANTAR PUSTULOSIS (PPP)
Clinical trials for PALMOPLANTAR PUSTULOSIS (PPP) explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS (PPP) trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS (PPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease painful hand and foot blisters
Disease control Recruiting nowThis study tests a daily pill called ivarmacitinib in 60 adults with palmoplantar pustulosis (PPP), a long-term skin condition causing painful blisters on hands and feet. Participants take one 4mg pill daily for 12 weeks. Researchers will check if symptoms improve by at least 50%…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New hope for chronic hand and foot pustules: xeligekimab enters trial
Symptom relief Recruiting nowThis study tests a new biologic drug, Xeligekimab, in 10 adults with moderate to severe palmoplantar pustulosis (PPP) — a chronic skin condition causing painful pustules on the palms and soles. The goal is to see if the drug can reduce symptoms and improve quality of life. Partic…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: PHASE4 • Sponsor: First Hospital of China Medical University • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC